Background: Mismatch negativity (MMN) is the neurophysiological correlate of cognitive integration of novel stimuli. Although MMN is a well-established predictor of awakening in non-sedated comatose patients, its prognostic value in deeply sedated critically ill patients remains unknown. The aim of this prospective, observational pilot study was to investigate the prognostic value of MMN for subsequent awakening in deeply sedated critically ill patients. Methods: MMN was recorded in 43 deeply sedated critically ill patients on Day 3 of ICU admission using a classical 'oddball' paradigm that delivers rare deviant sounds in a train of frequent standard sounds. Individual visual analyses and a group level analysis of recordings were performed. MMN amplitudes were then analysed according to the neurological status (awake vs not awake) at Day 28. Results: Median (inter-quartile range) Richmond Assessment Sedation Scale (RASS) at the time of recording was À5 (range, from À5 to À4.5). Visual detection of MMN revealed a poor inter-rater agreement [kappa¼0.17, 95% confidence interval (0.07e0.26)]. On Day 28, 30 (70%) patients had regained consciousness while 13 (30%) had not. Quantitative group
level analysis revealed a significantly greater MMN amplitude for patients who awakened compared with those who had not [mean (standard deviation) ¼ À0.65 (1.4) vs 0.08 (0.17) mV, respectively; P¼0.003).
Conclusions: MMN can be observed in deeply sedated critically ill patients and could help predict subsequent awakening. However, visual analysis alone is unreliable and should be systematically completed with individual level statistics.
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Editors key points
Mismatch negativity (MMN) is a neurophysiological correlate of detection of cognitive integration of novel stimuli. Presence of MMN is known to predict awakening in non-sedated comatose patients. The authors investigated the predictive ability of MMN for subsequent awakening of deeply sedated critically ill patients. MMN amplitude was significantly greater in patients in whom eye opening and visual contact subsequently occurred within 28 days.
Despite the involved risks, deep sedation is still required in the management of about 20% of critically ill patients. 1e4 Deeply sedated critically ill patients are at risk to develop new brain dysfunction, such as delayed awakening and delirium, 5e7 which have a considerable impact on short-and long-term outcome. 3,8e15 Moreover, deep sedation can hamper the detection of either the occurrence or worsening of brain dysfunction in brain injured patients. 16, 17 Therefore, detecting and monitoring the occurrence of brain dysfunction and predicting an outcome in deeply sedated brain injured patients are major and challenging concerns. 18e22 We recently demonstrated that the assessments of brainstem reflexes, 23, 24 EEG, 25 or somatosensory and brainstem auditory evoked potentials 26 at the early stage of the ICU stay can predict 28-day mortality in deeply sedated critically ill patients. In addition to mortality, the prediction of awakening is also a relevant endpoint in these patients, especially those who required a prolonged deep sedation. Mismatch negativity (MMN) is an event-related potential (ERP) component that has been extensively demonstrated to be useful in predicting awakening in comas of various origins. 27e29 MMN is a neurophysiologic response which reveals the specific detection of rare and deviant sounds occurring in a train of frequent and standard sounds. MMN reveals an automatic and unconscious detection of novelty which requires good perceptual discriminative capacity and iconic memory. 28, 30 The presence of an MMN is associated with a higher chance of awakening from a coma in non-sedated patients. 27,29,31e40 Moreover, it has been shown that MMN can be recorded in sedated patients. However, the prognostic value of MMN in a cohort of deeply sedated critically ill patients remains to be assessed. In this prospective observational pilot study, we investigated if MMN could be observed in patients receiving deep sedation and whether it could be useful for predicting subsequent awakening in these patients.
Methods

Ethical statement
This prospective monocentric observational cohort study was approved by the local ethics committee 'Groupement Hospitalier Universitaire (GHU) Paris Nord, Comit e d'Ethique de Recherche Biom edicale' (approval number: CERB 11-071).
Written informed consent was obtained from the patients' legal representatives and the healthy control subjects for their participation in this study. The Strengthening the Reporting of Observational Studies in Epidemiology (STROBE) guidelines 46 were followed thoroughly.
Patients
Consecutive mechanically ventilated and sedated patients were enrolled into the study from January 2013 to December 2015. ERPs were recorded on Day 3 at the bedside in deeply sedated patients, defined as a Richmond Assessment Sedation Scale (RASS) <À3. 47 Postcardiac arrest and moribund patients, and patients in whom cerebral death was suspected and those suffering from pre-existing acquired neuropathies were not included. As hypothermia may influence evoked potentials, no recording whilst body temperature was below 35 C was done. 48e51 We also recorded ERPs from a control group of nine non-sedated, healthy subjects (five women, four men), age range 24e61 yr, mean age 39 (SD 14) yr, using the very same passive auditory odd ball paradigm procedure and equipment as that used for patients.
Baseline clinical data collection
Patient characteristics (i.e. age, sex), body weight, date and time of ICU admission, category of admission (medical or surgical), co-morbidities, pre-existing risk factors for delirium, main cause of critical illness and brain injury, the date and cause of initiation of mechanical ventilation (MV), and the date and cause of initiation and maintenance of sedation were collected. The Simplified Acute Physiological Score II (SAPS-II), 52 the Sequential Organ Failure Assessment (SOFA), 53 and key interventions and standard biological tests needed to calculate these scores were recorded. Baseline data collection was performed following a previously described method. 24 
Sedation and analgesia
The decision to initiate sedation and its subsequent management was overseen by the physicians in charge of the patient and followed recent guidelines. 9, 14 Sedation was administered through a continuous infusion of midazolam, propofol, or both, alone or in combination with sufentanil. Total cumulative doses of administered drugs at the time of neurophysiological examination were collected. The depth of sedation was monitored using the RASS, 47 performed every 4 h until awakening. Sedation was administrated as a titration aiming at obtaining the desired RASS. 47 The time of onset, the reason for administration, duration of sedation were collected and the time of awakening (defined by eye opening and visual contact >10 s or RASS !À1).
Neurological examination
At the time of recording, neurological examination, including assessment of brainstem reflexes, was performed by senior ICU physicians, either neurologists or specifically trained intensivists. 24 The Glasgow Coma Scale (GCS), the Full Outline of Unresponsiveness (FOUR) score, 54 and the RASS were assessed. Physicians in charge of the patient were not informed of the results of the neurophysiologic examination.
Methodology for event-related potential recording and analysis
Event-related potential recordings
A Dantec™/NatuseFrance Keypoint® (Paris, France) portable machine was used for evoked potentials acquisition. ERPs were elicited by a passive auditory oddball paradigm using duration and frequency deviant sound according to the classical technique. 27, 28, 32, 55 The stimuli were pure tones with a level of 80 dB delivered binaurally through inserted earphones. Some 85% of the stimulations were frequent (standard) stimuli and 15% were rare (deviant). Characteristics of the two types of auditory stimuli are as follows: the first stimulus consisted of a high frequency and long duration tone (2000 Hz and 100 ms) and the second stimulus of a lower frequency and shorter tone (1000 Hz and 50 ms). The stimulation protocol included an automatic crossed design using the higher frequency and longer tone stimulus as the rare (deviant) during the first half of the recordings, and as the frequent (standard) during the second half of the recordings.
28e30,55
ERPs were recorded with active electrodes positioned at Fz (frontal) and Cz (central) according to 10e20 EEG system. The reference electrode was set at the right mastoid and the ground electrode on the forehead. Sterile hypodermic needle electrodes were used and inter-electrode impedance was kept below 3 kOhms. The amplification factor was 75 000. The signal was bandpass filtered with an analogue 1e160 Hz filter and sampled every second from each stimulus onset. Elementary responses with amplitude greater or smaller than 10 mV were automatically rejected, thus eliminating eye movements and other artifacts. Standard and deviant responses were averaged online separately and stored when the average of 200 suitable deviant responses was reached. 29 After averaging, data were bandpass filtered with a 3e30 Hz and Butterworth filter of order six, to exclude baseline shifts and high-frequency noise. Blocks of averaged standard responses and of deviant ones were stored for off-line analysis. Note that as this clinical acquisition setting does not allow captures of individual trials, but performs an online averaging process, it does not allow performing individual inter-trials analysis.
Event-related potential analysis
Individual visual analyses of ERPs were separately performed by five trained neurophysiologists (E.A., B.R., F.F., J.S., and L.N.), blinded to the clinical data. P1/N1, MMN and P300 of each patient were scored as present or absent on a visual wave detection basis, according to a standardised criterion including waves' polarity, expected latency range, and a minimal amplitude threshold value using the superposed curves and the difference curve (deviant minus standard). The inter-observer agreement rates between five raters were assessed using Fleiss' kappa scores. ERP grand averages across subjects were computed and both conditions were compared using a sample-by-sample paired t-test. Differences were considered significant only if we could observe at least 10 consecutive P-values <0.05 (corresponding to effects lasting !10 ms). In addition to the visual analysis and in order to circumvent the impossibility to compute individual inter-trial statistics with our clinical setting, we quantified individual amplitude values of MMN for each patient during the time window defined on the group lever (on the grand average). Because of poor inter-rater agreement, we chose to estimate individual MMN amplitudes by subtracting deviant minus standard curves over the time window previously defined at the group level analysis (i.e. 250e269 ms). For controls, we measured individual P1, MMN, and P300 amplitudes from baseline to the peak. For patients, MMN amplitudes were measured on the subtracted curve (deviant minus standard) during the time window defined at the group level. Individual MMN amplitude values of patients who awakened and those who did not after discontinuation of sedation were then compared using a Wilcoxon rank-sum tests (bilateral). Finally, we computed correlations between these individual MMN values and variables of interest using Spearman correlation coefficients. All analyses were performed using the R statistical software version 3.4.0.
Follow-up
During sedation, GCS, FOUR, and RASS were assessed daily. After discontinuation of sedation, GCS and Confusion Assessment Method for the ICU (CAM-ICU) 11 were assessed daily for detecting awakening, consciousness recovery, and delirium. Coma was defined by GCS below 8, awakening by eye opening and visual contact >10 s (¼RASS !À1), delirium by a positive CAM-ICU, and consciousness recovery by GCS of 15 associated with a negative CAM-ICU. Duration of MV, sedation, and length of ICU stay; date of awakening, and when applicable, of death and the cause of death, were collected. Delayed awakening was defined by the absence of awakening within the first 3 days after discontinuation of sedation.
Results
Patient baseline characteristics and outcome data
From January 2013 to December 2015, 43 consecutive mechanically ventilated and deeply sedated patients were included. Baseline characteristics of the patients are presented in Table 1 . Fourteen (33%) patients were admitted to the ICU for brain injury and 29 (67%) for a non-neurological critical illness ( to À4.5) and 4 (2e6), respectively. Overall median (IQR) duration of sedation was 9.5 (4e14) days (Table 1) . By Day 28 of admission, 30 (70%) patients had awoken. All patients who had not awoken died by Day 28. Causes of death were brain death in two patients and multiple organ failure in 11 patients. A decision to limit active treatments occurred in three patients, without being based on the results of the ERPs. Patients who woke up exhibited less severe critical illness according to SAPS-II and SOFA scores, but GCS, RASS, and cumulative doses of midazolam, propofol, and sufentanil did not significantly differ between the two groups. Group analysis Figure 1 features grand average ERPs curves recorded at Cz and Fz scalp positions from the group of nine non-sedated healthy volunteers in our laboratory (A), the 43 deeply sedated critically ill patients (B), the subgroup of 13 deeply sedated critically patients who did not awaken (C), and the subgroup of 30 deeply sedated patients who awoke (D), using the same recording paradigm. The P1/N1 complex and the MMN were easily distinguishable in healthy volunteers. While the P1/N1 complex was challenging to be identified in deeply sedated critically ill patients, a significant MMN was observed at around 260 ms latency range (from 250 to 269 ms). Compared with non-sedated healthy controls, MMN was slightly delayed in deeply sedated critically ill patients. As featured in Figure 1 , ERPs obtained at the Fz location did not appear to be of added value compared with those recorded at Cz, which seemed relatively more robust and reproducible. We therefore limited quantitative analysis of ERP in this study to data obtained in the Cz position.
Event-related potential data
Visual interpretation
Individual analysis
MMN amplitudes computed on the time window defined at the group level in patients who awoke were significantly larger than in the group of patients who did not awaken: mean 
Discussion
Three main findings emerge from this study. First, the auditory MMN can be observed in critically ill patients receiving deep sedation. Second, the preservation of MMN seems to be associated with awakening after discontinuation of sedation. Third, classical visual interpretation of individual ERPs seems to be not reliable in the ICU. Compared with healthy volunteers, MMN observed in deeply sedated patients was of smaller amplitude and the P300 component was totally suppressed (Fig. 1) . These results are consistent with previously reported data describing the effects of deep sedation on brain signals.
56e59 Human and primate study of general anaesthesia supports the view that sedative agents such as ketamine (an N-methyl-D-aspartate antagonist) and propofol (a GABA-A agonist) reduce neural complexity and disrupt brain network connectivity, leading to a dramatic decrease of the EEG signal power and ERP components. 60e63 Using the local-global ERP paradigm, 64, 65 which dissociates two hierarchical levels of auditory predictive coding by examining the brain responses to first order (local) and second order (global) sequence violations, Uhrig and colleagues 63 demonstrated that both propofol and ketamine preserve initial auditory processing, but disturb shortand long-term auditory predictive coding mechanisms in primates.
As previously described for non-sedated comatose patients, the observed relationship between 'preserved MMN' and 'occurrence of awakening' after discontinuation of sedation could be explained by a better preservation of higher cortical function. The current results are complementary to our previous studies on prognostication in deeply sedated critically ill patients which probed the predictive value of brainstem and sub-cortical functions, yielding a systematic approach for the ICU physician.
23e26 Indeed, in these populations, abolition of cough reflex, heterogeneous abolition of brainstem reflexes, increased SSEP intracranial conduction time, and absence of EEG reactivity are associated with increased mortality, while the presence of MMN seems to be associated with awakening. However, we would like to emphasise that these clinical or neurophysiologic tests can be used for assessing the patients' severity but not to support decision for care limitations or withdrawal. We also acknowledge that a multimodal approach integrating these clinical and neurophysiological markers should be tested in a larger cohort. This is the purpose of a multicentre observational study that we are currently conducting (ClinicalTrials. gov number: NCT02395861). Although group analysis is valuable in a research setting, for a clinical use, clinicians need reliable individual results. In this study we used a typical evoked potential recorder very similar to common equipment available in any clinical neurophysiological department. Contrary to research devices, these clinical devices perform an online averaging of trials which precludes any further inter-trial statistics. Our results clearly confirmed that this traditional visual interpretation, although reliable for other evoked potentials analysis (such as somatosensory, brainstem auditory, or visual evoked potentials), is totally unreliable for the interpretation of ERPs in the very unfavourable signal/noise ratio ICU environment. We think that any further study should enable inter-trial statistics. However, if the research community generally agrees on the need of statistics for ERPs interpretation, several concerns have been raised on the important variability of the methods across studies and there is still no gold standard. 66, 67 As we were able to demonstrate the existence of an MMN at the group level, we could probe individual MMN amplitudes accordingly to the latency observed at the group level. This methodological approach was to some extent validated by the fact that the MMN amplitudes were correlated with the occurrence of awakening after discontinuation of sedation. However, we acknowledge that the overlap of MMN values between patients who will eventually awake compared with those who will not suggest that this method of amplitude estimation on a defined time window should be used with caution in a clinical setting. An alternative solution allowing some inter-trial reliability while using clinical devices that perform online average, could have been to separate the total number of stimulations in a few (e.g. four or five) different averaged series (e.g. of 50 deviants and around 300 standards) to visually assess the reproducibility of ERPs across a series during the recording. This suggestion has been included in recent guidelines. 68 
Study limitations
As our aim was to assess the predictive value for awakening of MMN in deeply sedated patients, we have opted to study both primarily brain-injured and non-brain-injured patients. MMN has previously been shown as predictive of awakening in comatose patients independently of the aetiology of the coma. 32 Trying to identify neurophysiologic differences between brain-injured and non-brain-injured patients might have been hampered by a lack of power. As we did not adjust statistical tests for multiple comparisons, our results should be viewed as exploratory. This limitation is mitigated by the fact that we tested a small number of scientific hypothesesdthose pertaining to the association of a preserved MMN and awakening. One may argue that the prognostic value of MMN could simply reflect the negative effect of an over sedation, as it was correlated with RASS and cumulative dose of midazolam. In addition to sedation, the MMN amplitude might also depend on many other factors, notably the severity of organ failures. Indeed, it tended to be related to the SOFA score. As we previously discussed, it is difficult to disentangle these two possibly combined effects on brain responses. 23, 26 We hypothesised an interaction between these two factors: the same amount of sedative agent could have a stronger effect on brain functions according to the intensity of critical illness, reflecting the way the brain dysfunction. However, only investigating a larger cohort would enable not only addressing the respective influence of critical illness and sedation, but also identifying other factors (i.e. type of sedative agents, duration of sedation etc.).
Conclusion
This pilot study suggests that the preservation of MMN is predictive of awakening in deeply sedated critically ill patients, primarily brain-injured or not. However, the detection of MMN cannot be based on visual analysis. Our result needs to be confirmed on a larger cohort and with robust individual inter-trial statistics. Investigating with a multimodal approach on a larger cohort is warranted for confirming these results, to identify new determinants of MMN, and to confirm its prognosis value against other neurological and neurophysiologic responses.
